Saturday 17 October 2026
Export PTIX’s income statement to Excel — free account
Atrinsic Inc.
PTIX Healthcare Biotechnology
In the quarter to June 2026, EPS grew 61.3% and free cash flow grew 46.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.75
0.05
−6.25%
Follow PTIX
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
3.17 | 0.77 | 0.70 | 1.34 | 13.83 | 7.18 | 6.41 | 2.00 | 0.02 | 1.50 |
Net Debt/EBITDA |
0.71 | 0.26 | 0.25 | (0.29) | 2.71 | 2.31 | 0.92 | 0.33 | 0.01 | 0.52 |
Debt/Assets |
0.00% | 0.00% | 33.17% | 156.26% | 2.88% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | (0.44) | (1.19) | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.61 | 0.42 | 0.28 | 0.53 | 0.62 | 0.56 | 0.74 | 0.76 | 0.49 | (2.05) |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.02) | (1.31) | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(170.17) | (826.46) | (131.20) | (10.36) | (8.33) | (25.87) | (42.03) | — | (2.50) | (3.01) |
| (122.26%) | (507.24%) | 414.27% | 285.71% | (102.88%) | (42.18%) | (94.48%) | (236.06%) | 182.34% | (117.22%) | |
| (91.43%) | (206.42%) | (227.51%) | (296.10%) | (75.77%) | (37.24%) | (80.91%) | (175.98%) | (351.29%) | 73.16% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (253.66%) |
Return on Tangible Assets |
(185.32%) | 1,212.66% | 493.21% | (1,137.81%) | (44.08%) | (51.40%) | (136.33%) | (545.39%) | 72.52% | 260.22% |
Average Days of Receivables |
— | — | — | — | — | — | — | — | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.57 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(7.53) | (5.85) | (2.66) | (7.31) | (10.64) | (6.47) | (12.42) | (12.05) | (0.33) | (1.21) |
Cash per Share |
9.20 | 3.35 | 4.36 | 3.64 | 39.42 | 25.88 | 13.08 | 5.25 | 0.00 | 0.65 |
Shareholders Equity per Share |
6.66 | (1.15) | (3.46) | (6.23) | 37.79 | 22.44 | 11.83 | 2.90 | (0.92) | 1.12 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.66 | (1.15) | (3.46) | (6.23) | 37.79 | 22.44 | 11.83 | 2.90 | (0.92) | 1.12 |
Free Cash Flow |
(1.38) | (1.07) | (0.49) | (1.35) | (2.80) | (2.00) | (3.85) | (4.22) | (1.77) | (2.81) |
Working Capital |
1.22 | (0.21) | (0.36) | 0.22 | 10.26 | 6.92 | 3.54 | 0.94 | (4.95) | 0.51 |
Capital Expenditures |
— | — | — | — | — | 0.00 | (0.15) | — | — | 0.00 |
Net Current Asset Value |
1.22 | (0.21) | (0.63) | (1.15) | 9.94 | 6.92 | 3.54 | 0.94 | (4.95) | 0.51 |
| Other line items | ||||||||||
Quick Ratio |
3.00 | 0.68 | 0.67 | 1.02 | 12.97 | 7.12 | 6.19 | 1.95 | 0.02 | 1.46 |
Depreciation/Fixed assets |
0.10 | 0.50 | 39.00 | 0.00 | 0.00 | 61.56 | 0.92 | 0.69 | 0.00 | 110.73 |
Cash ROIC |
(47.51%) | (266.47%) | (110.01%) | (150.67%) | (13.56%) | (13.40%) | (49.89%) | (147.86%) | 35.82% | (68.07%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | 0.00 | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(7.53) | (5.85) | (2.66) | (7.31) | (10.64) | (6.47) | (11.94) | (12.05) | (0.33) | (1.21) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.01) | (0.48) | 0.00 | 0.00 | 0.00 |
Average Payables |
0.15 | 0.18 | 0.55 | 0.72 | 0.69 | 0.79 | 0.72 | 0.80 | 0.95 | 0.96 |
Average Assets |
2.47 | 1.24 | 0.77 | 0.86 | 5.97 | 9.55 | 6.18 | 3.14 | 1.02 | 1.87 |
Average Common Equity |
1.85 | 0.50 | (0.42) | (0.89) | 4.40 | 8.43 | 5.29 | 2.34 | (1.97) | (1.17) |
Capex to Sales |
— | — | — | — | — | 0.00 | 0.00 | — | — | 0.00 |
Columns are period end dates · fundamentals updated 28 Sep 2026